16P - Prognostic value of cyclooxygenase 2, enhancer of zeste homolog 2 and p53 evaluated by quantitative image analysis in malignant NSCLC
|Date||28 March 2014|
|Session||Lunch and poster display session|
|Topics|| Lung and other Thoracic Tumours
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
K. Hainis1, A.M. Athanasiadou2, E. Haini3, A. Tsipis2, M. Gonidi4, P. Athanassiadou2
Cyclooxygenase 2 (COX-2), Enhancer of Zeste Homolog 2 (EZH-2) and p53 overexpression is seen in many malignancies including lung cancer. The aim of this study was to investigate the usefulness of the expression of COX-2, p53 and EZH-2 in NSCLC using an image analysis system on immunostained specimens with regard to biological behavior of the tumor.